Charles DeBattista

Publication Details

• Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy.

  Smith DL, Angst MS, Brock-Utne JG, DeBattista C. Acta Anaesthesiol Scand. 2003; 47 (9): 1064-6

  The object of this study was to test whether substituting part of the methohexital dose with the short-acting opioid remifentanil would prolong seizure duration in middle-aged patients while providing a similar depth of anesthesia as with methohexital alone. This has been reported for the combined use of methohexital and remifentanil in elderly patients, but has not been investigated in middle-aged patients likely to require a higher total dose of methohexital for inducing anesthesia.

  PubMedID: 12969096